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Opioids today remain effective pain relievers, 
but are highly addictive. In our research, we 
propose a series of non-addictive opioid 
derivatives that will bind preferentially in peripheral 
tissue where inflammation occurs (pH = 6.5) and 
not in physiological conditions (pH = 7.4).
A pH-specific opioid derivative is aimed to induce 
selective binding. The pH-sensitivity is attributed 
to the addition of a fluorine on a beta-carbon to 
the ionic binding site, effectively destabilizing the 
amine group.
The binding of the fluoromorphine derivatives are 
specific to peripheral opioid receptors within 
inflamed tissue. Derivative will theoretically not 
bind to opioid receptors located in the brain, 
effectively lessening the central nervous system 
(CNS) response and lowering adverse side effects. 
Methods
Electronic structure calculations were optimized with GaussView 6 and computed with 
Gaussian 16, Rev. B.01 using the Keck Computational Research Cluster at Chapman 
University. From direct treatment of the aqueous phase reaction (1), we calculate the overall 
change in Gibbs free energy for the aqueous deprotonation (2). The reported pKa values 
are calculated using this reported change in free energy (3).
(1) Morphine-H+(aq) → Morphine(aq) + H
+
(aq)
(2) ΔGaq= Gaq(Morphine) – Gaq(Morphine-H
+) + Gaq(H
+)
Next steps include using machine learning technology 
to simulate ligand-receptor binding of the derivatives 
to (1) the active site and (2) allosteric site of the 
µ-opioid receptor. Preliminary data from simulations 
will include basic binding affinity, as well as 
quantitative estimate of drug likeness (QED) and 
synthetic accessibility scores (SAS) to ensure 
derivatives remain realistic synthetic options to act on 
drug targets.
Percent protonation is directly related to binding 
affinity. By keeping a high percent protonation in 
inflamed tissue, binding in inflamed peripheral 
tissues is encouraged while central opioid receptors 
at physiological pH are not activated. The most 
promising candidates are D-fluoromorphine β-C1 
and D-fluoromorphine β-C2.  Both structures 
maintain high protonation in inflamed tissue, while 
seeing a significant decrease in percent protonation 
in physiological tissue relative to morphine. The 
dissected ring structure encourages high binding 
affinity, while the fluorination beta to the binding site 
promotes selectivity in inflamed tissue. This 
encourages strong binding in sites of inflammation 
and pain, while discouraging binding within central 
tissues.
The benzomorphan drug class involves the dissection of 
C and D rings of morphine (Tbl. 1 - Morphine); this 
decreases the drug’s rigidity, which encourages a more 
fitted  binding of the ligand to the receptor. 
The proposed fluoromorphine derivatives, 
D-fluoromorphine β-C1 and D-fluoromorphine β-C2, 
lack the C and D rings, similar to the benzomorphans. 
We hypothesize that the combination of the induction by 
fluorine and proposed increase in binding affinity will 
allow the derivatives to preferentially bind in inflamed 
tissue. 
Tbl. 1. The table includes the computationally calculated pKa values of morphine, dissected morphine, 
D-fluoromorphine β-C1, and D-fluoromorphine β-C2.  The percent protonation of morphine, dissected morphine, 
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Percent protonation calculations based on pH environment are performed using a 
modified Henderson-Hasselbalch equation:
(4) 
(5)  
(3) 
